Opportunities

Kallman Worldwide is thrilled to bring decades of experience organizing events and exhibit space in Latin America. Our strong working relationship with the organizers, Informa Markets locally in Brazil and across the globe (Middle East, North Africa, Africa & Asia), ensures efficiency and access to everyone who can get things done.

Building off of a solid 26+ year foundation representing the U.S. at Arab Health, we are approaching Hospitalar 2021 Brazil as the next great growth opportunity.  As the world leader in health and medical innovation, the USA plays a unique, multifaceted role in helping Latin America realize its vision and plans. Our experience in the region (we’re here as often as ten times a year and have a fully staffed office in Santiago, Chile) gives you a big head-start to overcome any obstacle — and jump on any opportunity.

Work with us to lock in your location, fast-track your forms and maximize your impact at this important, influential event. No matter where you operate in the industry pipeline, Kallman will make sure you have the attention you need to succeed at Hospitalar 2021!

Joan Williams
Joan Williams
Deputy Director
Show Focus

Brazil is the largest healthcare market in Latin America and spends 9.1 percent of its GDP in healthcare. Of the approximately 6,400 hospitals, 70 percent are private. There are approximately 495,000 hospital beds, 96,000 healthcare supplementary services, 432,000 physicians, 144,000 dentists and 70,000 drugstores.

An aging population and poor management of resources in the healthcare sector offer opportunities for U.S. products and services.

In Brazil, the healthcare market is price-driven, mostly towards products that are manufactured in country. Quality is also important and companies must meet all sanitary registration requirements to sell to the Government. U.S. companies should consider cost-saving concepts and make clear the benefits of new technologies in marketing and promotional materials.

Leading Sub-Sectors

Pharmaceuticals and Nutritional Supplements
Brazil ranks among the top six markets in size for drugs and pharmaceuticals with sales of $28.4 billion in 2018 including taxes (Source: Sindusfarma). In 2018, Brazil increased imports by 9.7 percent in medicines and raw materials, reaching $7.2 billion. For high value-added medicines, the United States and Europe are the main exporters to Brazil, while China, India, and Ireland are the main suppliers of raw ingredients. Leading areas of opportunities include: chronic diseases, e.g. blood pressure, diabetes, cardio, contraceptives, rare diseases, generic drugs; and infectious diseases, e.g. HIV and Hepatitis C, weight loss, vitamins and sports nutrition.

Medical Devices
For medical devices, the market size is approximately $10.5 billion. The consumption of healthcare products increased 13.3 percent in 2018. (Source: Abimed) In 2018, Brazil increased imports of medical devices 21.8 percent, reaching $5.4 billion. Imported medical devices hold 80 percent of the market in Brazil and the United States represents 29 percent of this share. Brazil is the 14th largest market for U.S. medical devices and second in Latin America, after Mexico. In 2018, U.S. medical device exports to Brazil reached $953 million, an increase of 9.6 percent from the previous year. (Source: Census Bureau, U.S. Department of Commerce)

Health IT
For Healthcare IT, the Ministry of Health announced possible investments of more than $450 million by 2019 to digitalize the public basic care units of the country’s Unified Health System (SUS). Private hospitals are also investing in technology, and several new hospitals are formalizing their progress by obtaining international certificates for data management and reduction of paper use. The Federal Council of Medicine is in discussion to regulate the market for Telemedicine, which could open opportunities for U.S. companies to deliver solutions for teleconsultation, telediagnostic and data safety. Brazilian hospitals are also investing in minimally invasive technology for complex procedures, such as stents and catheters. One source also reported that by 2018, there were 41 types of equipment for robotic surgery in the country.

U.S. companies can be competitive in the Brazilian market when offering high quality, innovative products at a competitive price.

Show Data

Hospitalar 2020 by the numbers:

  • 1,200+ exhibitors
  • 70+ participating countries
  • 90,000 visitors